Combined effects of botulinum toxin type A and repetitive transcranial magnetic stimulation with intensive motor training immediately after injection in a patient with chronic stroke: A case report.
Botulinum Toxins, Type A
/ therapeutic use
Combined Modality Therapy
Humans
Injections, Intramuscular
Male
Middle Aged
Muscle Spasticity
/ physiopathology
Neuromuscular Agents
/ therapeutic use
Stroke
/ physiopathology
Stroke Rehabilitation
/ methods
Transcranial Magnetic Stimulation
Upper Extremity
/ physiopathology
Botulinum toxin type A
Rehabilitation
Repetitive transcranial magnetic stimulation
Stroke
Journal
Journal of hand therapy : official journal of the American Society of Hand Therapists
ISSN: 1545-004X
Titre abrégé: J Hand Ther
Pays: United States
ID NLM: 8806591
Informations de publication
Date de publication:
Historique:
received:
01
04
2017
revised:
15
01
2018
accepted:
20
01
2018
pubmed:
22
7
2018
medline:
5
3
2020
entrez:
21
7
2018
Statut:
ppublish
Résumé
Single case report. A previous study clarified that spasticity and motor function were improved by combined treatment with botulinum toxin type A (BTX) injection and 1-Hz repetitive transcranial magnetic stimulation (rTMS) with intensive motor training at 4 weeks after injection. However, it is not clear whether 1-Hz rTMS with intensive motor training immediately after BTX injection also improves spasticity and motor function in stroke patients. The purpose of this case report is to test the short- and long-term effects of BTX injection and rTMS with intensive motor training on the spasticity, motor function, and usefulness of the paretic hand in a stroke patient. A 64-year-old male, who suffered from a right cerebral hemorrhage 53 months previously, participated in the present study. BTX was injected into the spastic muscles of the affected upper limb. He then received the new protocol for a total of 24 sessions. The Modified Ashworth Scale (MAS), Fugl-Meyer Assessment (FMA), and Motor Activity Log, consisting of the amount of use and quality of movement scales, were assessed before and immediately after BTX injection, at discharge, and monthly for up to 5 months after discharge. For the short-term effects of the therapy, the MAS scores of the elbow and wrist, FMA score, and quality of movement score improved. For the long-term effects of the therapy, the MAS score of the fingers, FMA score, and amount of use score improved for up to 5 months after discharge. The present case report showed the improvement of all assessments performed in the short and/or long term and suggest the possibility of shortening the intervention period of combined therapy of BTX and rTMS with intensive motor training.
Identifiants
pubmed: 30025843
pii: S0894-1130(17)30081-9
doi: 10.1016/j.jht.2018.01.008
pii:
doi:
Substances chimiques
Neuromuscular Agents
0
Botulinum Toxins, Type A
EC 3.4.24.69
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
519-524Informations de copyright
Copyright © 2018 Hanley & Belfus. Published by Elsevier Inc. All rights reserved.